<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Virol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1096-9071</journal-id><journal-id journal-id-type="publisher-id">JMV</journal-id><journal-title-group><journal-title>Journal of Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">0146-6615</issn><issn pub-type="epub">1096-9071</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7283725</article-id><article-id pub-id-type="doi">10.1002/jmv.26067</article-id><article-id pub-id-type="publisher-id">JMV26067</article-id><article-categories><subj-group subj-group-type="overline"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Ratcheting down the virulence of SARS&#x02010;CoV&#x02010;2 in the COVID&#x02010;19 pandemic</article-title><alt-title alt-title-type="right-running-head">LETTER TO THE EDITOR</alt-title></title-group><contrib-group><contrib id="jmv26067-cr-0001" contrib-type="author" corresp="yes"><name><surname>Brufsky</surname><given-names>Adam</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8080-7960</contrib-id><xref ref-type="aff" rid="jmv26067-aff-0001">
<sup>1</sup>
</xref><address><email>brufskyam@upmc.edu</email></address></contrib><contrib id="jmv26067-cr-0002" contrib-type="author"><name><surname>Lotze</surname><given-names>Michael T.</given-names></name><degrees>MD, FACS</degrees><xref ref-type="aff" rid="jmv26067-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="jmv26067-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Hematology&#x02010;Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital</named-content>
<institution>University of Pittsburgh School of Medicine</institution>
<city>Pittsburgh</city>
<named-content content-type="country-part">Pennsylvania</named-content>
</aff><aff id="jmv26067-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Surgery</named-content>
<institution>UPMC Hillman Cancer Center</institution>
<city>Pittsburgh</city>
<named-content content-type="country-part">Pennsylvania</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Adam Brufsky, MD, PhD, Department of Hematology&#x02010;Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, University of Pittsburgh School of Medicine, Suite 4628, 300 Halket St, Pittsburgh, PA 15213.<break/>
Email: <email>brufskyam@upmc.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>6</month><year>2020</year></pub-date><elocation-id>10.1002/jmv.26067</elocation-id><history><date date-type="received"><day>09</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>5</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals LLC <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 Wiley Periodicals LLC</copyright-statement><license license-type="open-access"><license-p>Open access.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JMV-9999-na.pdf"/><counts><fig-count count="0"/><table-count count="0"/><page-count count="2"/><word-count count="1472"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:10.06.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<named-content content-type="salutation">To the Editor,</named-content>
</p><sec sec-type="opening-section" id="jmv26067-sec-0010"><p>Muller's ratchet<xref rid="jmv26067-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> predicts that when mutation rates are high and a significant proportion of mutations are deleterious, a kind of irreversible ratchet mechanism will gradually decrease the mean fitness of small populations of asexual organisms.<xref rid="jmv26067-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> In cell culture, serial passage of genetically bottlenecked vesicular stomatitis virus, which grew quite rapidly on HeLa cells, severely reduced in fitness and virulence within 20 passages in a novel BHK host cell.<xref rid="jmv26067-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> Genetic bottlenecks are likely important in intraspecies viral transmission.<xref rid="jmv26067-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> RNA&#x02010;based viruses are particularly prone to repeated bottleneck events due to high genetic variability and large fluctuations in population size which can lead to dramatic fitness losses or even viral extinction.<xref rid="jmv26067-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>
</p><p>Conversely, recombination events with other homologous viruses can lead to emergence of novel properties, particularly during periods of replication and transmission in zoonotic hosts. Coronaviruses (CoVs) utilize a highly conserved replication strategy, making vaccines focusing on this vulnerability highly attractive. Subgenomic RNAs are transcribed by discontinuous transcription regulatory sequences, conserved nucleotides located near the 5&#x02032;&#x02010;end of the genome. Recombination events are thus limited in their ability to propagate in the CoV family.<xref rid="jmv26067-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>
</p><p>Although RNA viruses typically have the ability to change rapidly (HIV and HCV) creating so&#x02010;called quasi&#x02010;species with profound differences in viral replicants due to the infidelity latent in the RNA polymerases, this appears to be less so with proofreading enzymes enabling restitution in the CoVs. Viral fitness is largely determined by the ability to propagate within the host and the host species, some reflecting that the most virulent strains are less successful from a broad host/pathogen perspective given that it ultimately limits viral spread. Genetic bottlenecks are created by interaction of viral variants and their host revealing a narrow range of genotypes successful over time.<xref rid="jmv26067-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>
</p><p>Genetic bottlenecks are likely to occur quite frequently with RNA&#x02010;based respiratory viruses since respiratory droplets often contain only one to two infectious particles per droplet.<xref rid="jmv26067-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Modeling suggests that such bottlenecks likely drive down the virulence of a pathogen due to stochastic loss of the most virulent phenotypes.<xref rid="jmv26067-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>
</p><p>There may be evidence of bottleneck genetic selection with other viruses. In Ebola, mutations arose during the 2013 to 2016 outbreak which were postulated to increase or decrease virulence.<xref rid="jmv26067-bib-0009" ref-type="ref">
<sup>9</sup>
</xref> In a macaque model of Ebola, attenuation was suggested, as monkeys infected with Ebola strains isolated from later in the epidemic did have improved survival.<xref rid="jmv26067-bib-0010" ref-type="ref">
<sup>10</sup>
</xref>
</p><p>During the severe acute respiratory syndrome (SARS) epidemic of 2003 to 2004, several stable mutations of SARS&#x02010;CoV were detected suggestive of bottleneck genetic selection. One of these mutations, a 29&#x02010;nucleotide deletion of ORF 8, arose early in the outbreak, was less pathogenic in cell culture, and was postulated to result in a loss of viral fitness due to a founder effect.<xref rid="jmv26067-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> Interestingly, multiple stable spike protein nonsynonymous substitutions, among others found in various SARS&#x02010;CoV protein coding sequences, were found in the later stages of the SARS outbreak as the substitution rate of the coding sequences slowed through time.<xref rid="jmv26067-bib-0012" ref-type="ref">
<sup>12</sup>
</xref>
</p><p>Variation in SARS&#x02010;CoV&#x02010;2 spike proteins have been described, and one of these stable nonsynonymous substitutions, D614G, predicts for increased probability of protein glycosylation at a canonical NXS/T site at residue 616 of the viral spike protein, and correlates with differences in mortality and possibly transmissibility from coronavirus disease&#x02010;2019 (COVID&#x02010;19) observed comparing both coasts of the United States.<xref rid="jmv26067-bib-0013" ref-type="ref">
<sup>13</sup>
</xref> Additional stable nonsynonymous spike protein mutations of SARS&#x02010;CoV&#x02010;2, including a stable nonsynonymous R408I variant in the receptor binding domain, predicting for decreased viral binding and decreased virulence, have now been described.<xref rid="jmv26067-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>, <xref rid="jmv26067-bib-0015" ref-type="ref">
<sup>15</sup>
</xref>
</p><p>Several of these mutations are predicted to increase or decrease protein glycosylation. A model of viral infection postulates that SARS&#x02010;CoV&#x02010;2 infection of the dendritic cell, the type II pneumocyte of the lung, and the endothelial cell is mediated through the DC/L&#x02010;SIGN/ACE2/CD209/CD147 complex found on these cells. Decreased glycosylation of the protein spike of SARS&#x02010;CoV&#x02010;2 should reduce viral binding to DCL&#x02010;SIGN and thus reduce viral uptake by these cells.<xref rid="jmv26067-bib-0016" ref-type="ref">
<sup>16</sup>
</xref> This should result in a decrease in viral virulence and possibly attenuation.</p><p>There are some clues arising from studies of virulence of various SARS&#x02010;CoV&#x02010;2 isolates. Viral strains isolated from various patients with COVID&#x02010;19 in Wuhan can vary as much as 270&#x02010;fold in viral load and cytopathogenicity in Vero E6 culture.<xref rid="jmv26067-bib-0017" ref-type="ref">
<sup>17</sup>
</xref> These strains contain a number of stable nonsynonymous coding mutations in the spike protein as well as other viral proteins. A protein interactome analysis suggests a rich source of other possible nonsynonymous SARS&#x02010;CoV&#x02010;2 protein coding alterations that could plausibly alter the virulence of the virus.<xref rid="jmv26067-bib-0018" ref-type="ref">
<sup>18</sup>
</xref>
</p><p>The involvement of Muller's ratchet in the pathogenesis and trajectory of the COVID&#x02010;19 pandemic should be explored. Examination of the distribution of nonsynonymous SARS&#x02010;COV&#x02010;2 mutations in symptomatic vs minimally symptomatic patients with COVID&#x02010;19 as the pandemic evolves could help support such involvement. Genomic analysis from SARS&#x02010;CoV&#x02010;2 isolates from Arizona<xref rid="jmv26067-bib-0019" ref-type="ref">
<sup>19</sup>
</xref> and Singapore<xref rid="jmv26067-bib-0020" ref-type="ref">
<sup>20</sup>
</xref> reveal possible founder mutation deletions in ORF 7 and ORF 8 consistent with the attenuating 29&#x02010;nucleotide deletion in ORF 8 in SARS&#x02010;CoV found early in the SARS epidemic.<xref rid="jmv26067-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>
</p><p>Muller's Ratchet should also be considered in developing vaccines for the disease, balancing natural decreases in virulence and limiting recombination events.</p></sec><sec sec-type="COI-statement" id="jmv26067-sec-0020"><title>CONFLICT OF INTERESTS</title><p>The authors declare that there are no conflict of interests.</p></sec></body><back><ref-list id="jmv26067-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="jmv26067-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jmv26067-cit-0001">
<string-name>
<surname>Muller</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>The relation of recombination to mutational advance</article-title>. <source xml:lang="en">Mutat Res Mol Mech Mutagen</source>. <year>1964</year>;<volume>1</volume>(<issue>1</issue>):<fpage>2</fpage>&#x02010;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0027-5107(64)90047-8</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jmv26067-cit-0002">
<string-name>
<surname>Duarte</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Moya</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Domingo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Holland</surname>
<given-names>J</given-names>
</string-name>. <article-title>Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>1992</year>;<volume>89</volume>(<issue>13</issue>):<fpage>6015</fpage>&#x02010;<lpage>6019</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.13.6015</pub-id>
<pub-id pub-id-type="pmid">1321432</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jmv26067-cit-0003">
<string-name>
<surname>McCrone</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Lauring</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Genetic bottlenecks in intraspecies virus transmission</article-title>. <source xml:lang="en">Curr Opin Virol</source>. <year>2018</year>;<volume>28</volume>:<fpage>20</fpage>&#x02010;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2017.10.008</pub-id>
<pub-id pub-id-type="pmid">29107838</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jmv26067-cit-0004">
<string-name>
<surname>Elena</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Miralles</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cuevas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Moya</surname>
<given-names>A</given-names>
</string-name>. <article-title>The two faces of mutation: extinction and adaptation in RNA viruses</article-title>. <source xml:lang="en">IUBMB Life</source>. <year>2000</year>;<volume>49</volume>(<issue>1</issue>):<fpage>5</fpage>&#x02010;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/713803585</pub-id>
<pub-id pub-id-type="pmid">10772334</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jmv26067-cit-0005">
<string-name>
<surname>Graham</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Deming</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Deming</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Yount</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Baric</surname>
<given-names>RS</given-names>
</string-name>. <article-title>Evaluation of a recombination&#x02010;resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform</article-title>. <source xml:lang="en">Commun Biol</source>. <year>2018</year>;<volume>1</volume>(<issue>1</issue>):<fpage>179</fpage>
<pub-id pub-id-type="doi">10.1038/s42003-018-0175-7</pub-id>
<pub-id pub-id-type="pmid">30393776</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jmv26067-cit-0006">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Roossinck</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Genetic bottlenecks reduce population variation in an experimental RNA virus population</article-title>. <source xml:lang="en">J Virol</source>. <year>2004</year>;<volume>78</volume>(<issue>19</issue>):<fpage>10582</fpage>&#x02010;<lpage>10587</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.19.10582-10587.2004</pub-id>
<pub-id pub-id-type="pmid">15367625</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jmv26067-cit-0007">
<string-name>
<surname>Stilianakis</surname>
<given-names>NI</given-names>
</string-name>, <string-name>
<surname>Drossinos</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Dynamics of infectious disease transmission by inhalable respiratory droplets</article-title>. <source xml:lang="en">J R Soc Interface</source>. <year>2010</year>;<volume>7</volume>(<issue>50</issue>):<fpage>1355</fpage>&#x02010;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1098/rsif.2010.0026</pub-id>
<pub-id pub-id-type="pmid">20164087</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jmv26067-cit-0008">
<string-name>
<surname>Bergstrom</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Mcelhany</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Real</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>1999</year>;<volume>96</volume>(<issue>9</issue>):<fpage>5095</fpage>&#x02010;<lpage>5100</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.9.5095</pub-id>
<pub-id pub-id-type="pmid">10220424</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jmv26067-cit-0009">
<string-name>
<surname>Wong</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Naturally occurring single mutations in ebola virus observably impact infectivity</article-title>. <source xml:lang="en">J Virol</source>. <year>2018</year>;<volume>93</volume>(<issue>1</issue>):<elocation-id>e01098&#x02010;18</elocation-id>
<pub-id pub-id-type="doi">10.1128/JVI.01098-18</pub-id>
<pub-id pub-id-type="pmid">30333174</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jmv26067-cit-0010">
<string-name>
<surname>Marzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chadinah</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Haddock</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Recently identified mutations in the Ebola virus&#x02010;Makona genome do not alter pathogenicity in animal models</article-title>. <source xml:lang="en">Cell Rep</source>. <year>2018</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1806</fpage>&#x02010;<lpage>1816</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.027</pub-id>
<pub-id pub-id-type="pmid">29742435</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jmv26067-cit-0011">
<string-name>
<surname>Muth</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Roth</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Attenuation of replication by a 29 nucleotide deletion in SARS&#x02010;coronavirus acquired during the early stages of human&#x02010;to&#x02010;human transmission</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<elocation-id>15177</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-018-33487-8</pub-id>
<pub-id pub-id-type="pmid">30310104</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jmv26067-cit-0012">
<collab collab-type="authors">Molecular</collab>
. <article-title>Evolution of the SARS coronavirus during the course of the SARS epidemic in China</article-title>. <source xml:lang="en">Science</source>. <year>2004</year>;<volume>303</volume>(<issue>5664</issue>):<fpage>1666</fpage>&#x02010;<lpage>1669</lpage>. <pub-id pub-id-type="doi">10.1126/science.1092002</pub-id>
<pub-id pub-id-type="pmid">14752165</pub-id></mixed-citation></ref><ref id="jmv26067-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jmv26067-cit-0013">
<string-name>
<surname>Brufsky</surname>
<given-names>A</given-names>
</string-name>. <article-title>Distinct viral clades of SARS&#x02010;CoV&#x02010;2: implications for modeling of viral spread [published online ahead of print April 20, 2020]</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.25902</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jmv26067-cit-0014">
<string-name>
<surname>Jia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Analysis of the mutation dynamics of SARS&#x02010;CoV&#x02010;2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity [published online ahead of print April 11, 2020]</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.09.034942</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jmv26067-cit-0015">
<string-name>
<surname>Korber</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Spike mutation pipeline reveals the emergence of a more transmissible form of SARS&#x02010;CoV&#x02010;2 [published online ahead of print April 30, 2020]</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.29.069054</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jmv26067-cit-0016">
<string-name>
<surname>Brufsky</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lotze</surname>
<given-names>M</given-names>
</string-name>. <article-title>DC/L SIGNs of hope in the COVID&#x02010;19 pandemic [published online ahead of print May 06, 2020]</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.25980</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jmv26067-cit-0017">
<string-name>
<surname>Yao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Patient&#x02010;derived mutations impact pathogenicity of SARS&#x02010;CoV&#x02010;2 [published online ahead of print April 23, 2020]</article-title>. <source xml:lang="en">medRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.14.20060160</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jmv26067-cit-0018">
<string-name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Jang</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Bouhaddou</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>A SARS&#x02010;CoV&#x02010;2 protein interaction map reveals targets for drug repurposing [published online ahead of print April 30, 2020]</article-title>. <source xml:lang="en">Nature</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jmv26067-cit-0019">
<string-name>
<surname>Su</surname>
<given-names>YCF</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>BE</given-names>
</string-name>, et al. <article-title>Discovery of a 382&#x02010;nt deletion during the early evolution of SARS&#x02010;CoV&#x02010;2 [published online ahead of print March 12, 2020]</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.03.11.987222</pub-id>
</mixed-citation></ref><ref id="jmv26067-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jmv26067-cit-0020">
<string-name>
<surname>Holland</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Kaelin</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Maqsood</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>An 81 nucleotide deletion in SARS&#x02010;CoV&#x02010;2 ORF7a identified from sentinel surveillance in Arizona (Jan&#x02010;Mar 2020) [published online ahead of print May 01, 2020]</article-title>. <source xml:lang="en">J Virol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1128/JVI.00711-20</pub-id>
</mixed-citation></ref></ref-list></back></article>